Design and rationale of CATO, a Phase IIA, randomized, double-blind, placebo-controlled study of single or repeated intravenous administration of umbilical cord-derived mesenchymal stromal cells in ischemic cardiomyopathy.

Roberto Bolli, Xian-Liang Tang, Joshua M Hare, Raul D Mitrani, Emerson C Perin, João Ac Lima, Barry E Hurwitz, Dinesh Kalra, Gurnoor Singh, Russell G Saltzman, Lina V Caceres, Adriana Nettina, Yee-Shuan Lee, Ketty Bacallao, Edward Grant